[
  {
    "ts": null,
    "headline": "Moderna, Inc. (MRNA) Is a Trending Stock: Facts to Know Before Betting on It",
    "summary": "Moderna (MRNA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
    "url": "https://finnhub.io/api/news?id=630fe21771facb8aaa5f8115baa0db0f50544256562497e837763b37dd3894aa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742589794,
      "headline": "Moderna, Inc. (MRNA) Is a Trending Stock: Facts to Know Before Betting on It",
      "id": 133327501,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna (MRNA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
      "url": "https://finnhub.io/api/news?id=630fe21771facb8aaa5f8115baa0db0f50544256562497e837763b37dd3894aa"
    }
  },
  {
    "ts": null,
    "headline": "Q4 Earnings Review: Therapeutics Stocks Led by BioMarin Pharmaceutical (NASDAQ:BMRN)",
    "summary": "As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the therapeutics industry, including BioMarin Pharmaceutical (NASDAQ:BMRN) and its peers.",
    "url": "https://finnhub.io/api/news?id=d707e8f3b0cc0fa822c090325019c202720f707ddbcc4a275332705e626f8505",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742547929,
      "headline": "Q4 Earnings Review: Therapeutics Stocks Led by BioMarin Pharmaceutical (NASDAQ:BMRN)",
      "id": 133325382,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the therapeutics industry, including BioMarin Pharmaceutical (NASDAQ:BMRN) and its peers.",
      "url": "https://finnhub.io/api/news?id=d707e8f3b0cc0fa822c090325019c202720f707ddbcc4a275332705e626f8505"
    }
  }
]